吉美瑞生

Biotech/Healthcare

Jimei Ruisheng is building an integrated value chain covering foundational research, preclinical development, clinical trials, and commercialization of regenerative medicine products. The company isolates and expands regenerative cells derived from different organs and combines them with clinical…

Latest round: Series B (2022)